politics

Pharmaceutical Hub initiative targets 70% import dependence to build a self-sufficient health sector

Pharmaceutical Hub initiative targets 70% import dependence to build a self-sufficient health sector

Ghana has taken a significant step towards overhauling its healthcare and industrial landscape with the launch of the Ghana Pharmaceutical Manufacturing Policy (GPMP). Speaking at the event, the Presidential Coordinator for the Ghana Pharmaceutical Hub, Dr Bernice Makafui Brempong, who is also a pharmacist, said the policy represents a strategic framework for addressing longstanding challenges, including access to finance, infrastructure and raw materials.

Ghana has taken a significant step towards overhauling its healthcare and industrial landscape with the launch of the Ghana Pharmaceutical Manufacturing Policy (GPMP).

The policy, approved by Cabinet and launched on October 28, at the Africa Trade House, aims to reverse the country's 70 per cent dependence on imported medicines by building a sustainable, competitive and integrated pharmaceutical ecosystem.

The launch brought together key government officials, including the Minister for Trade, Agribusiness and Industry, Elizabeth Ofosu-Adjare, alongside industry stakeholders, diplomats and representatives of the National Vaccine Institute (NVI).

Speaking at the event, the Presidential Coordinator for the Ghana Pharmaceutical Hub, Dr Bernice Makafui Brempong, who is also a pharmacist, said the policy represents a strategic framework for addressing longstanding challenges, including access to finance, infrastructure and raw materials.

“This achievement is central to President John Dramani Mahama’s vision of positioning Ghana as a pharmaceutical manufacturing hub in Africa,” the Coordinator said.

She noted that while the previous administration had provided financial support to local manufacturers, experience had shown that financial backing alone was insufficient.

“Our ambition is to build an ecosystem where manufacturers can thrive,” she added, pointing to Section 7.7 of the new policy, which identifies a purpose-built pharmaceutical park or hub as a “top priority of the Government”.

The policy sets the stage for the Ghana Pharmaceutical Hub, a presidential national legacy initiative under the government’s 24-hour economy programme.

According to the Coordinator, the Hub will give practical expression to the policy by bringing together manufacturers, input suppliers, research facilities and shared infrastructure.

The proposed Phase Two of the Hub, located in the Central Region, will focus on producing active pharmaceutical ingredients, herbal medicines and raw materials. It will also include the local production of excipients such as pharmaceutical-grade corn starch, corn syrup and ethyl alcohol, strengthening the link between agriculture and pharmaceutical manufacturing.

Dr Brempong, who also serves as the Senior Executive in charge of Investments in Healthcare and Pharmaceuticals at the Office of the President, stressed that contract manufacturing would be a crucial component of the Hub, allowing smaller companies to utilise shared, ready-to-use facilities.

“Not every pharmaceutical company can afford to build its own manufacturing facility,” she noted. “Through shared infrastructure... the Hub seeks to lower these barriers.”

Additionally, the Hub is expected to address a critical skills gap by equipping pharmacists with the skills needed for careers in industrial pharmacy, while creating opportunities for Ghana's approximately 1,600 unemployed pharmacists.

Speaking at the launch, the Chief Executive Officer of the National Vaccine Institute (NVI), Dr Sodzi Sodzi-Tettey, described the policy as the foundation for an “integrated ecosystem” strategy.

He outlined key provisions of the GPMP, including:

Dr Sodzi-Tettey noted that the policy provides answers to questions often raised by Development Finance Institutions (DFIs) when local manufacturers seek capital.

“When we approach these entities, a few questions are thrown back at us: How supportive is government of these initiatives?... I can confidently respond and say... Ghana has a Pharmaceutical Manufacturing Policy which articulates in clear, concrete terms the support that government is providing for the sector,” he said.

The launch also highlighted Ghana's recent strides in pharmaceutical production under the current John Mahama administration.

The NVI CEO noted that, under the previous Mahama administration, more than GH¢50 million was invested in at least three pharmaceutical companies, helping firms such as Ernest Chemist build state-of-the-art, GMP-compliant plants.

More recently, in August 2025, President Mahama allocated $50 million to the NVI, which has since established an mRNA laboratory at the Noguchi Memorial Institute for Medical Research, making Ghana one of only five African countries with the technology.

Furthermore, in May 2025, the NVI and Atlantic Lifesciences manufactured snake venom antiserum, Ghana's first biological product.

The country is also on track to produce anti-tetanus serum and its first vaccine, the tetanus-diphtheria vaccine, in 2027.

Atlantic Lifesciences has also been prequalified under the Africa CDC's Pooled Procurement Mechanism and awarded a contract to supply oxytocin to Africa.

As the government prepares to play its part, the Presidential Coordinator called on financial institutions to develop long-term financing solutions and urged healthcare institutions to prioritise domestic industries.

“The approval of this policy is an important achievement, but it is only the beginning,” she concluded.

“Our success will ultimately be measured by the factories established, investments attracted, medicines produced, jobs created and the competitiveness of Ghanaian manufacturers... Let us move from policy to implementation, from ambition to investment, and from dependence to greater domestic productive capacity.”

  • hub
  • pharmaceutical
  • policy
  • manufacturing
  • ghana
  • initiative
  • dependence
  • sector

Summaries and tags are generated automatically. Stay informed with VidiaNews.

Related news

Ghana to produce first locally manufactured vaccine by 2027 – Mahama
health

Ghana to produce first locally manufactured vaccine by 2027 – Mahama

Dr Sodzi Sodzi-Tettey, Chief Executive Officer of the National Vaccine Institute (NVI), disclosed this on Wednesday at the commissioning of the National Human Identification Laboratory and the Vaccine Research and Development facilities at the Noguchi Memorial Institute for Medical Research in Accra. The NVI was also collaborating with the Africa Centres for Disease Control and Prevention (Africa CDC) and the International Vaccine Institute to link Ghana’s research activities with other mRNA research hubs across Africa, he said.

Read →
Borteyman Sports Complex: gov’t courts private sector involvement to manage $145m facility
politics

Borteyman Sports Complex: gov’t courts private sector involvement to manage $145m facility

Government is exploring the possibility of a public-private partnership (PPP) to manage and maintain the Borteyman Sports Complex. Speaking before the floor of parliament on November 11, 2026, Sector Minister Kofi Adams said, ‘‘the PPP is intended to improve the long-term sustainability and commercial viability of the Borteyman Sports Complex, by generating revenue, enhancing visitor accommodation and services, and supporting the complex’s ongoing operations and maintenance,’’ he concluded.

Read →
Mahama commissions DNA laboratory to strengthen Ghana’s forensic investigations
health

Mahama commissions DNA laboratory to strengthen Ghana’s forensic investigations

President John Mahama has commissioned a national Human Identification Laboratory at the Noguchi Memorial Institute for Medical Research to strengthen Ghana’s capacity to conduct DNA testing for criminal investigations, disaster victim identification and disputed family relationships. Chief Executive Officer of the National Vaccine Institute, Dr Sodzi Sodzi-Tettey, said Ghana was making progress towards establishing a sustainable vaccine manufacturing ecosystem.

Read →
Children Take Their Place In Kenya’s 2027 Election As National Campaign Launches
politics

Children Take Their Place In Kenya’s 2027 Election As National Campaign Launches

Through this campaign, we want to harness that power so that millions of Kenyans hear directly from children, and so that their stories influence public policy and the choices we make about our country’s future,” said Eugene Mbugua, Founder of D&R Studios and D&R Impact. Speaking at the launch, Kennedy Odede, Founder and CEO of SHOFCO and Guest of Honour, said: “I grew up in Kibera, and I know what it means for a child to have something important to say with nobody asking.

Read →
Health Ministry pushes integration of traditional medicine into mainstream healthcare
health

Health Ministry pushes integration of traditional medicine into mainstream healthcare

The Ministry of Health has highlighted the role of traditional medicine in expanding access to healthcare, particularly in rural and underserved communities, as Ghana joined other stakeholders to mark the 24th African Traditional Medicine Day and the 27th Ghana Traditional Medicine Week. She cited the training of about 600 medical herbalists at the Kwame Nkrumah University of Science and Technology (KNUST) and the establishment of herbal medicine units in 55 public hospitals as key steps towards integrating traditional medicine into Ghana’s mainstream healthcare system.

Read →